Novocure Limited (NVCR) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Novocure Limited  (NASDAQ: NVCR)
 

Novocure Limited Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Novocure Limited's inventory turnover ratio, the ratio that measures Novocure Limited's ability to manage its supply chain, sequentially decreased to 4.02 in the second quarter 2026, but it does not raise any concerns as Novocure Limited continue to execute well, and the inventory turnover ratio remains above the average. Novocure Limited's average inventory processing period in the Jun 30 2026 quarter, has increased to 91 days, from 89 days, in the Mar 31 2026 quarter.

Within Healthcare sector 97 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 805 in the first quarter 2026, to 971.

NVCR Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Novocure Limited Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NVCR Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 5.01 % 10.11 % 17.17 % 0.02 % -0.57 %
Y / Y Cost of Sales Growth -0.88 % 1.06 % 25.97 % 26.45 % 19.67 %
Inventory Turnover Ratio (TTM) 4.02 4.08 4.17 4.11 3.87
NVCR's Total Ranking # 971 # 805 # 690 # 803 # 86
Average inventory processing period 91 89 87 89 94
Seq. Inventory Growth -2.84 % 5.71 % 5.13 % -2.75 % 1.88 %
Seq. Cost of Sales Growth 5.59 % -7.66 % -5.75 % 7.85 % 7.66 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 38
Healthcare Sector # 98
Overall Market # 971

Inventory Turnover Ratio Statistics
High Average Low
4.52 3.57 1.8
(Mar 31 2022)   (Mar 31 2017)



NVCR Company Profile >> Back to NVCR Efficiency Comparisons >> Compare NVCR Inventory Turnover Ratio to its Competitors

Financial Statements
Novocure Limited's Inventories $ 42 Millions Visit NVCR's Balance sheet
Novocure Limited's Cost of Revenues TTM $ 167 Millions Visit NVCR's Income Statement
What are NVCR's Sales? Visit NVCR's Sales by Segment

Other Inventory Turnover Ratios
Novocure Limited's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
NVCR's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for NVCR's Competitors
Inventory Turnover Ratio for NVCR's Suppliers
Inventory Turnover Ratio for NVCR's Customers

You may also want to know
NVCR's Sales Growth Rates NVCR's Pe Price to earnings ratio NVCR's Receivables Turnover Ratio NVCR's Stock Quote
NVCR's Net Income Growth Rates NVCR's Ps Price to Sales ratio NVCR's Sales per Employee NVCR's Asset Turnover Ratio
NVCR's Net Margin NVCR's Pb Price to Book ratio NVCR's Financial Strength Ratios NVCR's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Irhythm Holdings Inc   10.79 $ 235.967  Millions$ 22  Millions
Genedx Holdings Corp   10.27 $ 140.202  Millions$ 14  Millions
Tarsus Pharmaceuticals Inc   10.20 $ 43.740  Millions$ 4  Millions
Lantheus Holdings Inc   10.09 $ 619.325  Millions$ 61  Millions
Sotera Health Company  10.04 $ 547.412  Millions$ 55  Millions
Natera Inc   9.46 $ 672.186  Millions$ 71  Millions
Warby Parker Inc   9.27 $ 414.054  Millions$ 45  Millions
Hims and Hers Health Inc   9.23 $ 814.411  Millions$ 88  Millions
Polomar Health Services, Inc.  8.80 $ 1.233  Millions$ 0  Millions
Myriad Genetics Inc   8.31 $ 250.700  Millions$ 30  Millions
National Vision Holdings Inc   8.26 $ 841.416  Millions$ 102  Millions
Castle Biosciences Inc   8.14 $ 81.252  Millions$ 10  Millions
Autolus Therapeutics Plc  8.08 $ 99.009  Millions$ 12  Millions
The Oncology Institute Inc   8.03 $ 160.655  Millions$ 20  Millions
Nutriband Inc   7.92 $ 1.082  Millions$ 0  Millions
Novavax inc   7.61 $ 88.541  Millions$ 12  Millions
Inogen Inc   7.51 $ 196.617  Millions$ 26  Millions
Moderna Inc   7.50 $ 1,707.000  Millions$ 228  Millions
Cardiff Lexington Corporation  7.49 $ 4.042  Millions$ 1  Millions
Pulse Biosciences Inc   7.45 $ 1.182  Millions$ 0  Millions
Vanda Pharmaceuticals Inc   7.43 $ 13.506  Millions$ 2  Millions
Carlsmed Inc   7.42 $ 13.955  Millions$ 2  Millions
Adaptive Biotechnologies Corporation  7.26 $ 75.254  Millions$ 10  Millions
Lifemd Inc   7.22 $ 22.284  Millions$ 3  Millions
Phathom Pharmaceuticals Inc   7.01 $ 40.929  Millions$ 6  Millions
Carlisle Companies Incorporated  6.94 $ 3,299.600  Millions$ 476  Millions
Twist Bioscience Corporation  6.62 $ 207.413  Millions$ 31  Millions
Brightspring Health Services Inc   6.35 $ 4,108.953  Millions$ 647  Millions
Puma Biotechnology Inc   6.29 $ 58.199  Millions$ 9  Millions
Kewaunee Scientific Corporation  6.12 $ 196.836  Millions$ 32  Millions

Date modified: 2026-09-08T21:20:05+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.